Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC | 9,194,435 | reported | 17 Mar 2026 | tx 23+2,283,776−6,730,800 |
| Innoviva, Inc. | 5,658,705 | reported | 06 Mar 2025 | tx 9+505,000−1,618,295 |
| Sarissa Capital Acquisition Corp. | 5,000,000 | reported | 30 Oct 2020 | tx 2+3,333,333−31,250 |
| Savara Inc | 150,000 | reported | 30 Jun 2008 | tx 3+150,000 |
| Viskase Holdings, Inc. | 40,258 | reported | 02 Jan 2013 | tx 9+216,320 |
| VIVUS INC | 25,000 | reported | 30 Oct 2015 | tx 5+641,844 |
| BIOGEN INC. | 15,099 | reported | 15 Jun 2022 | tx 49+748,838−89,830 |
| AMYLIN PHARMACEUTICALS INC | 0 | reported | 08 Aug 2012 | tx 21+107,986.79−107,986.8 |
| MEDICINES CO /DE | 0 | reported | 06 Jan 2020 | tx 34+2,539,296−4,355,871 |
| ARIAD PHARMACEUTICALS INC | 0 | reported | 16 Feb 2017 | tx 21+9,853,173−21,853,173 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Mar 2026 | SALE | IRONWOOD PHARMACEUTICALS INC | 5,800 | 3.31 USD | |
| 13 Mar 2026 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 4,451 | 0.00 USD | |
| 17 Mar 2026 | SALE | IRONWOOD PHARMACEUTICALS INC | 6,725,000 | 3.05 USD | |
| 15 Dec 2025 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 4,178 | 0.00 USD | |
| 15 Sept 2025 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 11,718 | 0.00 USD | |
| 10 Jun 2025 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 45,000 | 0.00 USD | |
| 06 Mar 2025 | SALE | Innoviva, Inc. | 1,196,746 | 17.52 USD | |
| 05 Mar 2025 | SALE | Innoviva, Inc. | 270,374 | 17.63 USD | |
| 04 Mar 2025 | SALE | Innoviva, Inc. | 151,175 | 17.63 USD | |
| 18 Jun 2024 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 24,311 | 0.00 USD | |
| 15 Mar 2024 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 1,662 | 0.00 USD | |
| 15 Sept 2023 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 1,798 | 0.00 USD | |
| 06 Jun 2023 | PURCHASE | Innoviva, Inc. | 8,000 | 13.05 USD | anomaly |
| 05 Jun 2023 | PURCHASE | Innoviva, Inc. | 7,000 | 13.04 USD | anomaly |
| 30 May 2023 | PURCHASE | Innoviva, Inc. | 120,000 | 13.01 USD | |
| 25 May 2023 | PURCHASE | Innoviva, Inc. | 50,000 | 13.09 USD | |
| 26 May 2023 | PURCHASE | Innoviva, Inc. | 30,000 | 13.12 USD | |
| 11 May 2023 | PURCHASE | Innoviva, Inc. | 290,000 | 12.34 USD | first after silence |
| 15 Mar 2023 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 1,438 | 0.00 USD | |
| 15 Dec 2022 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 1,244 | 0.00 USD | |
| 15 Jun 2022 | GRANT_AWARD | BIOGEN INC. | 1,370 | 0.00 USD | |
| 15 Sept 2021 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 1,137 | 0.00 USD | |
| 01 Jul 2021 | GRANT_AWARD | BIOGEN INC. | 775 | 0.00 USD | |
| 15 Jun 2021 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 1,229 | 0.00 USD | |
| 02 Jun 2021 | GRANT_AWARD | IRONWOOD PHARMACEUTICALS INC | 22,766 | 0.00 USD |
4 purchases reported after at least 12 months of silence — most recent on 11 May 2023.